Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates. Gallagher ME, Sieben AJ, Nelson KN, Kraay ANM, et al. Nat Med 2020 Nov 23. pii: 10.1038/s41591-020-01172.

Read + Share

Amedeo Smart

Independent Medical Education

Gallagher ME, Sieben AJ, Nelson KN, Kraay ANM, et al. Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates. Nat Med 2020 Nov 23. pii: 10.1038/s41591-020-01172.
PMID: 33230343